{"id":2383,"date":"2024-08-05T15:27:00","date_gmt":"2024-08-05T05:27:00","guid":{"rendered":"https:\/\/webdev.sydney.edu.au\/kolling\/?post_type=news&#038;p=2383"},"modified":"2026-03-13T15:23:19","modified_gmt":"2026-03-13T04:23:19","slug":"valuable-new-funds-support-game-changing-cancer-research","status":"publish","type":"news","link":"https:\/\/kollinginstitute.org.au\/staging\/news\/valuable-new-funds-support-game-changing-cancer-research\/","title":{"rendered":"Valuable new funds support game-changing cancer research"},"content":{"rendered":"\n<p>Our ground-breaking leukaemia research at the Kolling Institute has received an important boost with the Cancer Council NSW announcing a $450,000 grant for Associate Professor Jenny Wang and her research team.<\/p>\n\n\n\n<p>The funds will help the development of a new therapy to greatly improve survival rates for those with acute myeloid leukaemia.<\/p>\n\n\n\n<p>This form of blood cancer is particularly aggressive, with less than a third of patients surviving five years after diagnosis.<\/p>\n\n\n\n<p>In many cases, the leukaemia does not respond well to chemotherapy and often returns.<\/p>\n\n\n\n<p>Associate Professor Wang welcomed the significant funding saying it will strengthen her research targeting the protective mechanism within the leukaemia stem cells which makes them resistant to chemotherapy.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>\u201cMy team has discovered a self-renewal pathway which enables leukaemia stem cells to protect themselves from chemotherapy and reproduce,\u201d she said.<\/p>\n\n\n\n<p>\u201cThere are currently no effective treatments to target these leukaemia-initiating cells but my team is developing a therapy to eliminate them and improve patient outcomes.<\/p>\n\n\n\n<p>\u201cEncouragingly, we anticipate this approach could help other cancers driven by tumour-initiating cells, such as cancers of the lung, breast, prostate, colon and brain.<\/p>\n\n\n\n<p>\u201cThese cancers may share the same survival mechanism as the leukaemia stem cells so the approach may also effectively target them.\u201d<\/p>\n<\/blockquote>\n","protected":false},"author":1,"featured_media":2384,"menu_order":0,"template":"","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[],"research-group-tax":[],"primary-research-area":[],"class_list":["post-2383","news","type-news","status-publish","has-post-thumbnail","hentry"],"acf":[],"uagb_featured_image_src":{"full":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/09\/thumb_Blog_Cancer-Council-Award-Night-Jenny-Wang_w550_h380_fcrop.webp",550,380,false],"thumbnail":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/09\/thumb_Blog_Cancer-Council-Award-Night-Jenny-Wang_w550_h380_fcrop-150x150.webp",150,150,true],"medium":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/09\/thumb_Blog_Cancer-Council-Award-Night-Jenny-Wang_w550_h380_fcrop-300x207.webp",300,207,true],"medium_large":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/09\/thumb_Blog_Cancer-Council-Award-Night-Jenny-Wang_w550_h380_fcrop.webp",550,380,false],"large":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/09\/thumb_Blog_Cancer-Council-Award-Night-Jenny-Wang_w550_h380_fcrop.webp",550,380,false],"1536x1536":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/09\/thumb_Blog_Cancer-Council-Award-Night-Jenny-Wang_w550_h380_fcrop.webp",550,380,false],"2048x2048":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/09\/thumb_Blog_Cancer-Council-Award-Night-Jenny-Wang_w550_h380_fcrop.webp",550,380,false]},"uagb_author_info":{"display_name":"ict-wordpress-support@sydney.edu.au","author_link":"https:\/\/kollinginstitute.org.au\/staging\/author\/ict-wordpress-supportsydney-edu-au\/"},"uagb_comment_info":0,"uagb_excerpt":"Our ground-breaking leukaemia research at the Kolling Institute has received an important boost with the Cancer Council NSW announcing a $450,000 grant for Associate Professor Jenny Wang and her research team. The funds will help the development of a new therapy to greatly improve survival rates for those with acute myeloid leukaemia. This form of&hellip;","_links":{"self":[{"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/news\/2383","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":1,"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/news\/2383\/revisions"}],"predecessor-version":[{"id":5402,"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/news\/2383\/revisions\/5402"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/media\/2384"}],"wp:attachment":[{"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/media?parent=2383"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/categories?post=2383"},{"taxonomy":"research-group-tax","embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/research-group-tax?post=2383"},{"taxonomy":"primary-research-area","embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/primary-research-area?post=2383"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}